![Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-(2S)-pyrrolidinecarboxylate]dirhodium(II)](https://static.cymitquimica.com/products/3D/img/FT180391.png "Cliccare per ingrandire")
Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-(2S)-pyrrolidinecarboxylate]dirhodium(II)
CAS: 179162-34-6
Rif. 3D-FT180391
| 5mg | 136,00 € | ||
| 10mg | 167,00 € | ||
| 25mg | 300,00 € | ||
| 50mg | 440,00 € | ||
| 100mg | 626,00 € |
Informazioni sul prodotto
- Tetrakis(1-((4-Alkyl(C11-C13)Phenylsulfo N-Yl)-(2S)-Pyrrolidinecarboxylate)Dirhod
- Tetrakis[(S)-(-)-N-(p-dodecylphenylsulfonyl)prolinato]dirhodium(II) Rh2(S-DOSP)4
Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-2S-pyrrolidinecarboxylate]dirhodium(II) is an organoiridium compound that can be used to synthesize vinyldiazoacetates. This compound is immobilized on a support and reacts with ethyl diazoacetate in the presence of prolinate to afford the corresponding vinyldiazoacetate. Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-2S-pyrrolidinecarboxylate]dirhodium(II) has been shown to be able to inhibit monoamine reuptake and exhibit antiinflammatory properties, which may be due to its ability to block the uptake of norepinephrine and serotonin.
Proprietà chimiche
Richiesta tecnica su: 3D-FT180391 Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-(2S)-pyrrolidinecarboxylate]dirhodium(II)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
